Catalent, Inc. is a holding company, which engages in the provision of delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products. It operates through the following segments: Softgel and Oral Technologies, Biologics, Oral and Specialty Delivery, and Clinical Supply Services. The Softgel and Oral Technologies segment offers formulation, development, and manufacturing services for soft capsules or softgels, as well as large-scale production of oral solid dose forms for pharmaceutical and consumer health markets and supporting ancillary services. The Biologics segment develops and produces biologic cell-line, cell therapy, and viral vector gene therapy, formulation for parenteral dose forms, which include prefilled syringes, vials, and cartridges, and analytical development and testing services for large molecules. The Oral and Specialty Delivery segment is composed of advanced formulation of a range of technologies along with integrated downstream clinical development and commercial supply solutions. The Clinical Supply Services segment is involved in packaging, storage, distribution, and inventory management of drugs and biologics in clinical trials. The company was founded in 1933 and is headquartered in Somerset, NJ.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
17,800
Frequently Asked Questions
What is Market Cap of Catalent Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Catalent Inc. market cap is $10.13B.
What is the 52-week high for Catalent Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Catalent Inc. 52 week high is $60.20 as of April 25, 2024.
What is the 52-week low for Catalent Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Catalent Inc. 52 week low is $31.45 as of April 25, 2024.
What is Catalent Inc. stock price today?
Catalent Inc. stock price today is $55.95.
What was Catalent Inc. stock price yesterday?
Catalent Inc. stock price yesterday was $56.03.
What is the PE ratio of Catalent Inc.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Catalent Inc.’s P/E ratio is -7.93.
What is the Price-to-Book ratio of Catalent Inc.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Catalent Inc. P/B ratio is 2.7416.
What is Catalent Inc.'s EBITDA?
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Catalent Inc.'s EBITDA is 28.61.
What is the 50-day moving average of Catalent Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Catalent Inc. 50-day moving average is $56.73.